Penumbra Revenue 2014-2022 | PEN

Penumbra annual/quarterly revenue history and growth rate from 2014 to 2022. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Penumbra revenue for the quarter ending June 30, 2022 was $0.208B, a 13.07% increase year-over-year.
  • Penumbra revenue for the twelve months ending June 30, 2022 was $0.806B, a 20.1% increase year-over-year.
  • Penumbra annual revenue for 2021 was $0.748B, a 33.4% increase from 2020.
  • Penumbra annual revenue for 2020 was $0.56B, a 2.38% increase from 2019.
  • Penumbra annual revenue for 2019 was $0.547B, a 23.03% increase from 2018.
Penumbra Annual Revenue
(Millions of US $)
2021 $748
2020 $560
2019 $547
2018 $445
2017 $334
2016 $263
2015 $186
2014 $126
2013 $89
Penumbra Quarterly Revenue
(Millions of US $)
2022-06-30 $208
2022-03-31 $204
2021-12-31 $204
2021-09-30 $190
2021-06-30 $184
2021-03-31 $169
2020-12-31 $167
2020-09-30 $151
2020-06-30 $105
2020-03-31 $137
2019-12-31 $145
2019-09-30 $140
2019-06-30 $134
2019-03-31 $128
2018-12-31 $121
2018-09-30 $112
2018-06-30 $110
2018-03-31 $103
2017-12-31 $96
2017-09-30 $84
2017-06-30 $81
2017-03-31 $73
2016-12-31 $73
2016-09-30 $67
2016-06-30 $65
2016-03-31 $58
2015-12-31 $54
2015-09-30 $50
2015-06-30 $42
2015-03-31 $39
2014-12-31
2014-09-30 $32
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $6.042B $0.748B
Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $227.578B 23.18
Edwards Lifesciences (EW) United States $62.887B 44.49
Alcon (ALC) Switzerland $36.987B 31.32
STERIS (STE) Ireland $20.913B 25.96
Teleflex (TFX) United States $11.693B 18.63
Fresenius Medical Care AG KGaA (FMS) Germany $10.936B 10.09
Globus Medical (GMED) United States $6.491B 32.38
Glaukos (GKOS) United States $2.370B 0.00
Integer Holdings (ITGR) United States $2.345B 18.34
Nevro (NVRO) United States $1.688B 0.00
Paragon 28 (FNA) United States $1.486B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.365B 20.90
Artivion (AORT) United States $0.860B 82.00